Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
23,209,909
-
Total 13F shares
-
396,349
-
Share change
-
+283,587
-
Total reported value
-
$1,720,900
-
Price per share
-
$4.34
-
Number of holders
-
8
-
Value change
-
+$1,231,900
-
Number of buys
-
7
Institutional Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q4 2021
As of 31 Dec 2021,
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
396,349 shares.
The largest 8 holders included
VANGUARD GROUP INC, Ayrton Capital LLC, BOOTHBAY FUND MANAGEMENT, LLC, Wealth Alliance, StoneX Group Inc., SABBY MANAGEMENT, LLC, Steward Partners Investment Advisory, LLC, and ADVISOR GROUP HOLDINGS, INC..
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.